Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outpatient coordination reform improves the sustainability of China's Urban Employee Basic Medical Insurance Fund.

Frontiers in public healthĀ·2024
Same author

Evaluation and correction methods for geometric errors of hydrostatic thrust bearings.

Scientific reportsĀ·2024
Same author

Predicting immunotherapy-related adverse events in late-stage non-small cell lung cancer with KARS G12C mutation treated with PD-1 inhibitors through combined assessment of LCP1 and ADPGK expression levels.

American journal of cancer researchĀ·2024
Same author

Enhancing genomic association studies in slash pine through close-range UAV-based morphological phenotyping.

Forestry researchĀ·2024
Same author

Co-encapsulation of probiotic Lactiplantibacillus plantarum and polyphenol within novel polyvinyl alcohol/fucoidan electrospun nanofibers with improved viability and antioxidation.

International journal of biological macromoleculesĀ·2024
Same author

Protocol for analyzing invadopodia formation and gelatin degradation.

STAR protocolsĀ·2024
Same journal

Macrophage-enriched GPR91 aggravates acute liver injury by inhibiting efferocytosis via the AC/cAMP/PPARĪ³ pathway.

Metabolism: clinical and experimentalĀ·2026
Same journal

Corrigendum to "TMEM41B contributes to atherosclerosis by promoting lipid synthesis in vascular smooth muscle cells via fatty acid synthase stabilization" [Metabolism 175 (2026) 156456].

Metabolism: clinical and experimentalĀ·2026
Same journal

Ghrelin predicts food consumption up to three hours prior to eating: A randomised controlled trial.

Metabolism: clinical and experimentalĀ·2026
Same journal

A translational model of MASLD-associated HFpEF defines mitochondrial dysfunction and cardiac plasticity during disease progression and regression.

Metabolism: clinical and experimentalĀ·2026
Same journal

SUMOylation of HMGCS1 triggers its ubiquitin-dependent degradation to alleviate hepatic steatosis.

Metabolism: clinical and experimentalĀ·2026
Same journal

Dynamic regulation of circulating endotrophin by changes in fat mass in humans.

Metabolism: clinical and experimentalĀ·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2025

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
10:56

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality

Published on: May 5, 2022

13.5K

Engineering organoids-on-chips for drug testing and evaluation.

Hui Wang1, Wan Zhu2, Cong Xu3

  • 1Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; University of Chinese Academy of Sciences, Beijing 100049, China.

Metabolism: Clinical and Experimental
|November 10, 2024
PubMed
Summary
This summary is machine-generated.

Organoids-on-chips merge stem cell organoids with micro-physiological systems for advanced drug screening. This innovative platform overcomes limitations of traditional models, offering more accurate human physiology replication.

Keywords:
Drug screeningEngineering strategiesMicrofluidicsOrganoids-on-chipsPreclinical-to-clinical conversionSafety assessment

More Related Videos

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

26.6K
Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip
09:46

Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip

Published on: February 17, 2023

1.7K

Related Experiment Videos

Last Updated: Jun 7, 2025

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
10:56

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality

Published on: May 5, 2022

13.5K
Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

26.6K
Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip
09:46

Reconstituting Cytoarchitecture and Function of Human Epithelial Tissues on an Open-Top Organ-Chip

Published on: February 17, 2023

1.7K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Drug Discovery

Background:

  • Traditional preclinical models like 2D cell cultures and animal studies have limitations in accurately predicting human physiological responses.
  • Organoids-on-chips represent a significant advancement, integrating stem cell-derived organoids with microfluidic technology.
  • This technology aims to create more biomimetic in vitro systems for enhanced drug development.

Purpose of the Study:

  • To review the challenges and requirements for effective preclinical drug screening models.
  • To highlight the capabilities of organoids-on-chips in replicating human physiology.
  • To explore the potential and obstacles in developing advanced organoids-on-chips for drug assessment.

Main Methods:

  • Review of current literature on organoids-on-chips in drug screening and safety evaluation.
  • Analysis of the features and benefits of organoids-on-chips compared to traditional models.
  • Discussion of recent advancements and future directions in the field.

Main Results:

  • Organoids-on-chips offer a superior platform for in vitro construction of biomimetic micro-physiological systems.
  • This technology authentically replicates human physiology, addressing limitations of conventional drug screening methods.
  • Recent studies demonstrate successful applications of organoids-on-chips in drug screening and safety assessments.

Conclusions:

  • Organoids-on-chips present a promising avenue for more accurate and efficient drug screening and safety evaluations.
  • Further development is needed to enhance the practicality and clinical translation of these sophisticated models.
  • Multidisciplinary innovation is key to accelerating the adoption of organoids-on-chips in healthcare and industry.